Physician profile
Alex Argyelan
NPI 1023436805
$8,681.46
in general payments reported to CMS, 2019-2025
33 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,147 · 2022: $4,285 · 2023: $508 · 2024: $539 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,042.78 | 2021-2022 | |
| Hologic Sales and Service, LLC | $544.97 | 2022-2025 | Aptima, Coolseal Generator, Acessa Provu System |
| Abbvie INC. | $321.43 | 2021-2023 | Orilissa, Lo Loestrin Fe |
| Merck Sharp & Dohme LLC | $226.89 | 2022-2025 | Gardasil 9, Gardasil |
| Organon LLC | $221.20 | 2021-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $146.30 | 2022-2025 | |
| Aspira Women'S Health INC | $129.04 | 2021-2022 | |
| Astellas Pharma US INC | $113.17 | 2024-2025 | Veozah |
| Agile Therapeutics, INC. | $82.29 | 2021-2022 | |
| Pfizer INC. | $71.26 | 2022-2024 | |
| Coopersurgical, INC. | $69.25 | 2021-2024 | Paragard T 380a |
| Exeltis, USA INC. | $65.25 | 2022-2024 | Slynd |
| Vertex Pharmaceuticals Incorporated | $63.93 | 2024-2025 | |
| Shield Therapeutics INC | $63.40 | 2023-2024 | Accrufer |
| Mylan Pharmaceuticals INC. | $58.75 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $58.40 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $47.16 | 2023 | Ultomiris |
| Therapeuticsmd, INC. | $46.96 | 2022 | |
| Biogen, INC. | $38.86 | 2024-2025 | Zurzuvae |
| Gynesonics, INC. | $33.33 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myovant Sciences INC. | $29.76 | 2022 | |
| Hologic INC | $24.00 | 2021 | |
| Exact Sciences Corporation | $19.40 | 2023 | Cologuard Collection Kit |
| Mimedx Group, INC. | $19.13 | 2025 | |
| Sobi, INC | $19.12 | 2022 | |
| Amgen INC. | $18.64 | 2022 | |
| Smith+Nephew, INC. | $18.25 | 2025 | "Acticoat 4"" X 4""", Pico 7 |
| Scynexis, INC. | $17.65 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.47 | 2024 | Exparel |
| Meditrina | $14.34 | 2023 | |
| Sumitomo Pharma America, INC. | $13.48 | 2023 | Myfembree |
| Evofem Biosciences, INC. | $13.34 | 2022 | |
| Avion Pharmaceuticals | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Argyelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.